Tag Archives: GlaxoSmithKline

Featured Stories

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two-Leading-Cancer-Groups-Issue-Call-for-Regulation-of-E-cigarettes-and-Research-on-Health-Risks

The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

J.J. Fuds, Inc. Pet Food Recalled - Listeria Contamination

J.J. Fuds, Inc. Pet Food Recalled Over Potential Listeria Contamination

J.J. Fuds, has recalled a specific lot of its J.J. Fuds Chicken Tender Chunks Pet Food over potential contamination with the dangerous, Listeria monocytogenes pathogen.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Zofran Blamed as Cause for Cleft Palate in New Lawsuit

Zofran Blamed as Cause for Cleft Palate in New Lawsuit

On October 3, 2016, a mother claimed that the active ingredient in the anti-nausea drug Zofran’s caused her son to develop cleft palate and cleft lip in the womb. The woman, from Oneida, New York, filed her case in the … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , |

FDA Scrutinizes Pfizer Study Evaluating Chantix Suicide Risks

FDA Scrutinizes Pfizer Study Detailing Chantix Suicide Risks

The U.S. Food and Drug Administration (FDA) is questioning whether or not Pfizer’s study of neuropsychiatric effects of Chantix, the smoking cessation drug, accurately reflects the risks. Pfizer conducted the clinical trial upon request from the FDA, following a high … Continue reading

Posted in Chantix, Pharmaceuticals | Tagged , , , , , , , |

Zofran Birth Defect Lawsuit Update: “Sequence Discovery” Issue

Zofran Birth Defect Case Update: “Sequence Discovery” Issue

Plaintiffs in more than 200 birth defect lawsuits have raised concerns over the pharmaceutical company GlaxoSmithKline’s (GSK) new proposal for Sequenced Discovery. Parents say the company neglected to warn patients and health experts of its anti-nausea drug Zofran’s alleged potential … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Federal Judge Denies Motion to Dismiss Claims in Zofran Birth Defect Cases

zofran-baby

A federal judge in Massachusetts has denied a motion by drug maker GlaxoSmithKline to dismiss cases alleging that the drug Zofran (ondansetron) caused birth defects on the grounds that federal law preempts state failure-to-warn claims. Federal law is the “supreme” … Continue reading

Posted in Birth Defects, Defective Products, Health Concerns, Legal News, Pharmaceuticals | Tagged , , , , |

Anti-nausea Medication Zofran Dangerous During First Trimester of Pregnancy

zofran

Zofran (ondansetron hydrochloride), manufactured by GlaxoSmithKline (GSK), is approved for use alone, or in combination with other medications, for the prevention of nausea and vomiting associated with chemotherapy and radiation therapy, and is used to prevent these symptoms following surgery. … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals | Tagged , , , , |

California Parents Sue GlaxoSmithKline over Child’s Heart Defect Allegedly Caused by Zofran Taken During Pregnancy

Parents Sue GlaxoSmithKline over Child’s Heart Defect

Alameda County, California, parents have filed a lawsuit against GlaxoSmithKline (GSK) for a heart defect their daughter suffered allegedly as a result of the mother being prescribed Zofran (ondansetron) while pregnant. This medication is used to prevent nausea and vomiting … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals | Tagged , , , |

Flu Vaccine Recalled Over Potency Problem

Flu Vaccine Recalled Over Potency Problem

Drug maker GlaxoSmithKline (GSK) has announced a voluntary recall for the remaining doses of its 2014-2015 Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes (PFS) flu vaccine. The company discovered a reduction in the vaccine’s potency that may reduce the vaccine’s effectiveness. Glaxo … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals | Tagged , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.